Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020326
Company: MEDIMMUNE ONCOLOGY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NEUTREXIN TRIMETREXATE GLUCURONATE EQ 25MG BASE/VIAL INJECTABLE;INJECTION Discontinued None No No
NEUTREXIN TRIMETREXATE GLUCURONATE EQ 200MG BASE/VIAL INJECTABLE;INJECTION Discontinued None No No
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/09/2005 SUPPL-15 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020326s015lbl.pdf
06/26/2002 SUPPL-13 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20326s11s13lbl.pdf
06/26/2002 SUPPL-11 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20326s11s13lbl.pdf

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English